Financing environment and regional heterogeneity regression results. by Qi Zhang (28502)

Subjects:

Instrumental variable regression results. by Qi Zhang (28502)

Subjects:

Spatial distribution of NS in the Greater Mundri Area, South Sudan. by Gasim Omer Elkhalifa Abd-Elfarag (13171021)

Subjects:

Early-stage and mature B lymphocytes significantly decreased but long-lived B lymphocytes increased in APRIL^-/-/BLyS^-/- group. by Natalie M. Bath (6316517)

Subjects:

Phase 2 significant effects. by Wendy C. Crone (2262169)

Phase 1 significant effects. by Wendy C. Crone (2262169)

The TRPA1 protein level in the heart from older mice is decreased. by Shuangtao Ma (704707)

Decreased <i>Resf1</i> in cell lines paradoxically decreases metastatic capacity. by Megan R. Majocha (18529925)

Prioritising public information leads to an overall decrease in cooperation occurring in networks. by Adam Lee Miles (14123916)

Bacterial groups that showed a significantly decreased abundance after antibiotic treatment (AMC and DOX group) compared to the control group (CON group). by Evangelia M. Stavroulaki (11840809)

The fraction of predicted heterozygotes that are set to “No Call” by RHA decreases as the size of the heterozygote cluster increases. by Orna Mizrahi-Man (42539)

Wilcoxon sign rank test for significance of the climate periods. by Francis Kibagendi Nyambariga (16425739)

Subjects:

Between the PCSO-524 group and the placebo group unpaired comparisons of the change between visits of quality of life and respiratory variables scores. by Nattapon Riengvirodkij (11268720)

Subjects:

A flow diagram outlining the number of dogs in each group during the study (visit 1 = day 0, visit 2 = day 35, and visit 3 = day 70). by Nattapon Riengvirodkij (11268720)

Subjects:

Distribution of quality of life and respiratory variables scores of all 3 visits (visit = day 0, visit 2 = day 35, and visit 3 = day 70) of the PCSO-524 group and the placebo group... by Nattapon Riengvirodkij (11268720)

Subjects:

The baseline characteristics of classifications and body condition score of the 2 groups (frequencies) at entry (visit 1, day 0). by Nattapon Riengvirodkij (11268720)

Subjects:

Distribution of continuous variables of all 3 visits (visit 1 = day 0, visit 2 = day 35, and visit 3 = day 70) of the PCSO-524 group and the placebo group. Results are shown as mea... by Nattapon Riengvirodkij (11268720)

Subjects:

Tricuspid regurgitation pressure gradient of all 17 dogs. by Nattapon Riengvirodkij (11268720)

Subjects:

Tricuspid regurgitation pressure gradient in the PCSO-524 and placebo groups. by Nattapon Riengvirodkij (11268720)

Subjects:

Number and percentage of AE patients with detectable Em2+ antibodies at different visits and significance level in binominal test. by Beate Grüner (301524)

Subjects: